{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-217434","form_type":"8-K","ticker":"KYTX","cik":"0001994702","company_name":"Kyverna Therapeutics, Inc.","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.775741+00:00","generated_at":"2026-05-17T05:42:52.294499+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Director Steve Liapis resigns from Kyverna board effective Sept 30, 2025","bullets":["Steve Liapis, Ph.D. notified the board of his resignation effective September 30, 2025.","Resignation is not due to any disagreement with the company's operations, policies, or practices.","Board size will be reduced from eight to seven directors upon resignation.","Christi Shaw, a current board member, appointed to the Audit Committee to fill the vacancy."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-217434","json":"https://secwatch.observer/filing/0001193125-25-217434.json","markdown":"https://secwatch.observer/filing/0001193125-25-217434.md","text":"https://secwatch.observer/filing/0001193125-25-217434.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/0001193125-25-217434-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/kytx-20250919.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:42:52.294499+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}